Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapk8tm1Wag mutation
(1 available);
any
Mapk8 mutation
(71 available)
|
|
|
homeostasis/metabolism
adipose tissue
|
• on a high fat high calorie diet the weight of the subcutaneous fat depot is reduced by 33% compared to wild-type
|
|
• on a high fat high calorie diet total body adiposity is decreased compared to wild-type
|
|
• on a high fat high calorie diet adipocytes are smaller compared to wild-type mice
|
|
• the weight of the epididymal fat pad is increased compared to wild-type
|
growth/size/body
|
• on a high fat high calorie diet homozygotes do not gain as much weight as wild-type mice
however, on a normal diet body weight is similar to wild-type
|
integument
|
• on a high fat high calorie diet the weight of the subcutaneous fat depot is reduced by 33% compared to wild-type
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapk8tm1Wag mutation
(1 available);
any
Mapk8 mutation
(71 available)
|
|
|
immune system
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus; however T and B cell development and B cell activation are normal
|
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus; however T and B cell development and B cell activation are normal
• after 24 hours of culture with low concentrations of anti-CD3 and anti-CD28 antibodies homozygous T cells produce less IL2
|
|
• reduced proliferation of lymph node but not splenic T cells after stimulation with low concentrations of anti-CD3 antibody
• however, the addition of IL2 to the culture medium increases T cell proliferation to a level similar to that of wild-type cells
|
hematopoietic system
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus; however T and B cell development and B cell activation are normal
|
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus; however T and B cell development and B cell activation are normal
• after 24 hours of culture with low concentrations of anti-CD3 and anti-CD28 antibodies homozygous T cells produce less IL2
|
|
• reduced proliferation of lymph node but not splenic T cells after stimulation with low concentrations of anti-CD3 antibody
• however, the addition of IL2 to the culture medium increases T cell proliferation to a level similar to that of wild-type cells
|
cellular
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus; however T and B cell development and B cell activation are normal
|
|
• reduced proliferation of lymph node but not splenic T cells after stimulation with low concentrations of anti-CD3 antibody
• however, the addition of IL2 to the culture medium increases T cell proliferation to a level similar to that of wild-type cells
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapk8tm1Wag mutation
(1 available);
any
Mapk8 mutation
(71 available)
|
|
|
vision/eye
N |
• normal thickness, cell count and cell density of retina INL and GCL at age P30
• normal lamination of retina at age P7, P14 and P30
• normal cell counts for retinal ganglion, horizontal, bipolar, amacrine, and Mueller cells
|
|
• 2.7-fold increase in S-opsin- and 5-fold increase in M-opsin-positive cells at age P30
|
|
• 1.4-fold increase in rhodopsin-positive cells at age P30
|
|
• increased density and cell count at age P30
• normal thickness though trending towards slightly thicker at age P30
|
|
• under photopic and scotopic conditions at age 1 month and 2 months
|
nervous system
|
• 2.7-fold increase in S-opsin- and 5-fold increase in M-opsin-positive cells at age P30
|
|
• 1.4-fold increase in rhodopsin-positive cells at age P30
|
neoplasm
|
• following adenovirus cre infection, mice exhibit increased lung tumor burden compared with control mice
|
respiratory system
|
• following adenovirus cre infection, mice exhibit increased lung tumor burden compared with control mice
|
growth/size/body
|
• decreased weight gain relative to Lepob single homozygotes
|
homeostasis/metabolism
immune system
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote
|
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote
|
|
• lymph node T cells display reduced proliferation in response to low concentrations of anti-CD3 antibody similar to either single homozygote
|
hematopoietic system
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote
|
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote
|
|
• lymph node T cells display reduced proliferation in response to low concentrations of anti-CD3 antibody similar to either single homozygote
|
cellular
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote
|
|
• lymph node T cells display reduced proliferation in response to low concentrations of anti-CD3 antibody similar to either single homozygote
|
immune system
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote
|
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote or in the double heterozygote
|
|
• lymph node T cells display reduced proliferation in response to low concentrations of anti-CD3 antibody similar to either single homozygote or in the double heterozygote
|
hematopoietic system
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote
|
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote or in the double heterozygote
|
|
• lymph node T cells display reduced proliferation in response to low concentrations of anti-CD3 antibody similar to either single homozygote or in the double heterozygote
|
cellular
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote
|
|
• lymph node T cells display reduced proliferation in response to low concentrations of anti-CD3 antibody similar to either single homozygote or in the double heterozygote
|
immune system
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote
|
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote or in the double heterozygote
|
|
• lymph node T cells display reduced proliferation in response to low concentrations of anti-CD3 antibody similar to either single homozygote or in the double heterozygote
|
hematopoietic system
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote
|
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote or in the double heterozygote
|
|
• lymph node T cells display reduced proliferation in response to low concentrations of anti-CD3 antibody similar to either single homozygote or in the double heterozygote
|
cellular
|
• anti-CD3 antibody stimulated double positive T cell apoptosis is reduced in the thymus similar to the reduction seen in either single homozygote
|
|
• lymph node T cells display reduced proliferation in response to low concentrations of anti-CD3 antibody similar to either single homozygote or in the double heterozygote
|
mortality/aging
|
• fewer than expected mice are found at weaning; however expected numbers are found at E12.5 to E15.5
|
nervous system
|
• at E12.5 the neural tube is open over the complete antero-dorsal extent of the brain in exencephalic mice
|
|
• at E15.5 in exencephalic mice, the brain tissue is expanded upward
|
|
• abnormal folding of the neuroepithelium is seen in exencephalic mice at E12.5
|
|
• at E12.5, in exencephalic mice the cerebral ventricles are absent
|
|
• at E15.5 in exencephalic mice, the diencephalon is enlarged
|
|
• at E15.5 in exencephalic mice, the cerebral hemispheres are displaced laterally
|
|
• some embryos display exencephaly with absence of the entire creanial roof at E12.5
|
embryo
|
• abnormal folding of the neuroepithelium is seen in exencephalic mice at E12.5
|
|
• at E12.5 the neural tube is open over the complete antero-dorsal extent of the brain in exencephalic mice
|
mortality/aging
nervous system
|
• at E9.25, reduced apoptosis is seen in the hindbrain especially along the edges of the neural folds
|
|
• at E10.5 increased apoptosis is seen in the forebrain neuroepithelium, especially in the lamina terminalis, the optic stalk and the trigeminal ganglia; however, no difference is seen at E9.25 or E10.5 in the number of proliferating cells
|
|
• at E10.5 increased apoptosis is seen in hindbrain neuroepithelium; however, no difference is seen at E9.25 or E10.5 in the number of proliferating cells
|
|
• the neuroepithelium is thickened and everted at the level of the fourth ventricle
• at E10.5 increased apoptosis is seen in the forebrain and hindbrain neuroepithelium; however, no difference is seen at E9.25 or E10.5 in the number of proliferating cells
|
|
• neural fold in the hindbrain region are elevated but the lateral edges do not bend medially to fuse
• this defect begins at the midbrain/hindbrain boundary and extends to the cervical/hinbrain boundary; however the forebrain and spinal neural folds are fused
|
|
• the lumen of the forebrain vesicles is incompletely formed
|
growth/size/body
homeostasis/metabolism
embryo
|
• the neuroepithelium is thickened and everted at the level of the fourth ventricle
• at E10.5 increased apoptosis is seen in the forebrain and hindbrain neuroepithelium; however, no difference is seen at E9.25 or E10.5 in the number of proliferating cells
|
|
• neural fold in the hindbrain region are elevated but the lateral edges do not bend medially to fuse
• this defect begins at the midbrain/hindbrain boundary and extends to the cervical/hinbrain boundary; however the forebrain and spinal neural folds are fused
|
cellular
|
• at E9.25, reduced apoptosis is seen in the hindbrain especially along the edges of the neural folds
|
|
• at E10.5 increased apoptosis is seen in the forebrain neuroepithelium, especially in the lamina terminalis, the optic stalk and the trigeminal ganglia; however, no difference is seen at E9.25 or E10.5 in the number of proliferating cells
|
|
• at E10.5 increased apoptosis is seen in hindbrain neuroepithelium; however, no difference is seen at E9.25 or E10.5 in the number of proliferating cells
|
nervous system
N |
• no mice display exencephaly and no indications of increased mortality are seen
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Map3k1tm1Yxia mutation
(0 available);
any
Map3k1 mutation
(62 available)
Mapk8tm1Wag mutation
(1 available);
any
Mapk8 mutation
(71 available)
|
|
|
vision/eye
|
• eyes are open at birth
• however, mice exhibit normal retinal morphology
|
vision/eye
|
• eyes are open at birth
• however, mice exhibit normal retinal morphology
|
vision/eye
|
• mice exhibit an eyelid closure defect compared with wild-type mice
|